Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Restricted Stock Units (Details)

v3.22.2.2
Stockholders' Equity - Restricted Stock Units (Details) - Unvested restricted stock units - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Number of Shares    
Number of Shares, Granted   850,000
Non-vested ending balance 850,000 850,000
Weighted Average Grant Date Fair Value    
Weighted Average Exercise Price Granted   $ 1.05
Weighted Average Exercise Price , ending balance $ 1.05 $ 1.05
Stock-based compensation expense $ 0 $ 0